ArticleJAMA2018

Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma.

Jerry A Krishnan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.